President and CEO of Krystal Biotech Inc (KRYS, Financial) Krish S Krishnan bought 25,000 shares of KRYS on 10/18/2018 at an average price of $20 a share. The total cost of this purchase was $500,000.
Krystal Biotech Inc is a biopharmaceutical company. It uses gene therapy treatments for patients suffering from rare debilitating disorders. Krystal Biotech Inc has a market cap of $231.890 million; its shares were traded at around $21.12 .
CEO Recent Trades:
- President and CEO, 10% Owner Krish S Krishnan bought 25,000 shares of KRYS stock on 10/18/2018 at the average price of $20. The price of the stock has increased by 5.6% since.
Directors and Officers Recent Trades:
- COO, 10% Owner Suma Krishnan bought 25,000 shares of KRYS stock on 10/18/2018 at the average price of $20. The price of the stock has increased by 5.6% since.
For the complete insider trading history of KRYS, click here
.